NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

How many patients did the company plan to enroll originally? 60? But with 40 patients enrolled, the company can draw definitive conclusion.

It was designed as a P1 of 40 patients with a 20 patient P2 follow up in the indications that were most responsive,

With 0 responses, they never started the 20 patient P2 extension.

And now they are redesigning the drug in pre-clincial work.